PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)
$5.74 -0.48 (-7.717%)
Analysed PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) News Sources
Phathom Pharmaceuticals Highlights New Cost-Effectiveness Data and Growing Clinical Interest in VOQUEZNA® (vonoprazan) at ACG 2026
12-10-2026
yahoo.com
Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026
19-10-2026
yahoo.com
Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA
23-10-2026
yahoo.com
PHAT Stock Eyes Worst Day In Nearly Two Years After Generic Drug Maker Challenges Key Drug’s Exclusivity
23-10-2026
stocktwits.com
Phathom Pharmaceuticals Provides Update on FDA Litigation
26-10-2026
yahoo.com
Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
29-10-2026
yahoo.com
Phathom Pharmaceuticals, Inc. (PHAT) Lags Q3 Earnings and Revenue Estimates
29-10-2026
yahoo.com
Phathom (PHAT) Q3 2026 Earnings Call Transcript
29-10-2026
fool.com
Phathom Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
29-10-2026
moby.co
What Phathom Pharmaceuticals (PHAT) Said on Its Q3 Earnings Call
29-10-2026
marketbeat.com
What is the current price of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The current price of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is $5.74.
PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) absolute price change since previous trading day?
The absolute price change of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) since the previous trading day is $-0.48.
PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) percentage price change since previous trading day?
The percentage price change of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) since the previous trading day is -7.717%.
What is the most recent average sentiment score for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The most recent average sentiment score for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The most recent sentiment for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is .
SEC-8K** Filing Available For PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.